Narcan Naloxone Hcl Spray
Product Images NDC 51662-1642

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Narcan Naloxone Hcl (NDC 51662-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pack (51662 1642 1)

Narcan Naloxone HCL 4 mg/.1mL nasal spray in a clear plastic blister pack with a white nasal applicator and attached label showing the product name Narcan, NDC 51662-1642, and the labeler HF Acquisition Co LLC DBA HealthFirst. The packaging includes a barcode and reference to the manufacturer's package insert.*

FDA Label Image

Rfid Label (51662 1642 1 Rfid Label)

A close-up image of a label containing a QR code and alphanumeric codes formatted with parentheses, including (01)00351662164211, (17)230919, (21)351662141212, and (10)HF1234TESTING. Text beneath states 'SEE MANUFACTURE'S INSERT' and 'DISTRIBUTED BY HF ACQUISITIONS CO., LLC MUKILTEO, WA 98275.' The label is related to Narcan Naloxone HCL nasal spray by HF Acquisition Co LLC.*

FDA Label Image

Rfid Label (51662 1642 2 Rfid Label)

A label featuring a barcode, human-readable numeric codes, and text details. The text instructs to see the manufacturer's insert and provides distributor information: HF Acquisitions Co., LLC located in Mukilteo, Washington 98275. The label includes numeric codes likely representing product identification and tracking information.*

FDA Label Image

Pack (51662 1642 2)

Narcan Naloxone HCL 4 mg/0.1 mL nasal spray by HF Acquisition Co LLC, DBA HealthFirst. The image shows the product box marked 'Not for Retail Distribution' containing 2 single-dose sprays for emergency treatment of opioid overdose. Two nasal spray devices are displayed outside the box.*

FDA Label Image

Directions (Narcan 1)

Instructional diagram for Narcan Naloxone HCL Nasal Spray 4 mg showing emergency use guidance for opioid overdose treatment. The image includes labeled parts of the nasal spray device (nozzle and plunger) and step-by-step instructions for checking if a person is overdosing, such as shaking and yelling "Wake up!" to the person.*

FDA Label Image

Carton Label (Narcan Carton Label)

Narcan Naloxone HCL Nasal Spray 4 mg carton displays product name prominently for emergency treatment of opioid overdose. Packaging shows two single-dose nasal spray devices of 0.1 mL each, designed for nasal use. Label includes directions with illustrations, drug facts, warnings, storage information, and manufacturer HF Acquisition Co LLC DBA HealthFirst.*

FDA Label Image

Directions (Narcan 2)

Instructional diagram for Narcan Naloxone HCL nasal spray detailing steps for administration: Step 2 gives directions to hold and insert the nasal spray device and press the plunger to give the first dose. Step 3 instructs to call 911 immediately. Step 4 advises watching the person for 2-3 minutes and giving a second dose if no waking occurs. Step 5 emphasizes staying until ambulance arrival, giving additional doses if necessary.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.